title: The paclitaxel-eluting Coroflex Please stent pilot study (PECOPS I) : the one-year clinical follow-up.
abstract: BACKGROUND
  The alleged superiority of drug-eluting stents over bare metal devices and those with passive coatings is diminished by a higher incidence of late target vessel thrombosis.
  
  
  RESULTS
  Therefore, the one-year clinical outcome of the paclitaxel-eluting Coroflex Please stent in patients with denovo coronary lesions was evaluated in the single-arm PECOPS I pilot study. The clinical data of 96/97 (99%) of the patients included per protocol and of 86/87 (98.9%) of those treated per protocol were available 13.1 +/- 1.8 months following stent deployment. In the inclusion and treatment per protocol groups the incidence of cardiac deaths was 1/96 (1%) and 1/86 (1.2%), of myocardial infarction 3/96 (3.1%) and 1/86 (1.2%), and of target lesion revascularization 9/96 (9.4%) and 8/86 (9.3%). In patients enrolled per protocol two early thromboses (2.1%) occurred one of which two days after premature discontinuation of clopidogrel. In patients treated per protocol one thrombosis was observed after 10 hours. The one-year event-free survival was 83/96 (86.5%) in patients enrolled per protocol and 75/86 (87.2%) in those treated per protocol.
  
  
  CONCLUSIONS
  The one-year clinical outcome of PECOPS I was within the range of other paclitaxel-eluting coronary stents. The relative small number of patients enrolled in PECOPS I precludes to infer any further conclusions.
authors: Clinical Research Institute, Center of Cardiovascular Diseases, Heinz-Meise-Strasse 100, 36199, Rotenburg an der Fulda, Germany.
authors: Martin
authors: M
authors: Unverdorben
authors: Ralf
authors: R
authors: Degenhardt
authors: Marcus
authors: M
authors: Wiemer
authors: Dieter
authors: D
authors: Horstkotte
authors: Henrik
authors: H
authors: Schneider
authors: Christoph
authors: C
authors: Nienaber
authors: Wolfgang
authors: W
authors: Bocksch
authors: Michael
authors: M
authors: Gross
authors: Michael
authors: M
authors: Boxberger
authors: Christian
authors: C
authors: Vallbracht
mesh_terms: D000368:Aged; D000077144:Clopidogrel; D003324:Coronary Artery Disease / Q000628:therapy*; D023903:Coronary Restenosis / Q000517:prevention & control; D003643:Death; D054855:Drug-Eluting Stents / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000209:etiology; D009204:Myocardial Revascularization; D017239:Paclitaxel / Q000008:administration & dosage*; D010865:Pilot Projects; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011446:Prospective Studies; D015996:Survival Rate; D013927:Thrombosis / Q000209:etiology*; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D050257:Tubulin Modulators / Q000008:administration & dosage*
chemical_list: D010975:Platelet Aggregation Inhibitors; D050257:Tubulin Modulators; D000077144:Clopidogrel; D013988:Ticlopidine; D017239:Paclitaxel
references: Coron Artery Dis. 1997 May;8(5):293-8
references: 9285182
references: J Am Coll Cardiol. 2006 Jan 3;47(1):175-81
references: 16386683
references: Circulation. 2005 Nov 22;112(21):3306-13
references: 16286586
references: JAMA. 2005 Aug 17;294(7):819-25
references: 16106007
references: Cathet Cardiovasc Diagn. 1994 Sep;33(1):61-75
references: 8001105
references: J Am Coll Cardiol. 2005 Apr 5;45(7):995-8
references: 15808753
references: J Am Coll Cardiol. 2005 Jun 21;45(12 ):2088-92
references: 15963413
references: J Am Coll Cardiol. 2007 Mar 13;49(10):1043-51
references: 17349883
references: N Engl J Med. 2004 Jan 15;350(3):221-31
references: 14724301
references: J Am Coll Cardiol. 2006 Jan 3;47(1):182-3
references: 16386684
references: Circulation. 2006 Feb 28;113(8):1108-13
references: 16490815
references: JAMA. 2006 Feb 22;295(8):895-904
references: 16493102
references: Circulation. 2001 Jul 24;104(4):473-9
references: 11468212
references: N Engl J Med. 2007 Mar 8;356(10):998-1008
references: 17296824
references: Eur Heart J. 2006 Dec;27(23):2784-814
references: 17020889
references: J Am Coll Cardiol. 2005 Mar 15;45(6):947-53
references: 15766834
references: Circulation. 2004 Apr 27;109(16):1942-7
references: 15078803
references: Circulation. 2005 Dec 20;112(25):3876-83
references: 16344384
references: J Cell Biol. 1981 Nov;91(2 Pt 1):589-94
references: 7309800
references: Circulation. 2007 Mar 20;115(11):1433-9; discussion 1439
references: 17344323
references: Circulation. 1997 Jul 15;96(2):636-45
references: 9244237
references: Eur Heart J. 2006 Sep;27(18):2189-95
references: 16893918
references: J Am Coll Cardiol. 2005 Mar 15;45(6):941-6
references: 15766833
references: N Engl J Med. 1995 Apr 13;332(15):1004-14
references: 7885406
references: J Clin Invest. 1995 Apr;95(4):1869-76
references: 7706494
references: N Engl J Med. 2005 Aug 18;353(7):653-62
references: 16105989
references: J Am Coll Cardiol. 1993 Dec;22(7):2033-54
references: 8245363
references: N Engl J Med. 2003 Oct 2;349(14):1315-23
references: 14523139
references: Catheter Cardiovasc Interv. 2006 May;67(5):703-10
references: 16575926
references: Clin Res Cardiol. 2006 Apr;95(4):195-203
references: 16598587
references: Circulation. 2006 Mar 21;113(11):1434-41
references: 16534015
references: Contrib Nephrol. 1989;74:58-65
references: 2702147
references: Clin Res Cardiol. 2007 Feb;96(2):86-93
references: 17180577
references: Catheter Cardiovasc Interv. 1999 May;47(1):102-6
references: 10385171
references: Lancet. 2007 Feb 24;369(9562):667-78
references: 17321312
references: Clin Res Cardiol. 2006 Jan;95 Suppl 1:i27-30
references: 16598544
references: Eur Heart J. 2006 Sep;27(18):2147-9
references: 16899473
references: Clin Res Cardiol. 2007 Feb;96(2):70-6
references: 17146605
references: JAMA. 2005 May 4;293(17):2126-30
references: 15870416
references: Circulation. 2003 Aug 19;108(7):788-94
references: 12900339
references: Z Kardiol. 2000 May;89(5):390-7
references: 10900668